SCHEMBL13023076

SCHEMBL13023076

CC(C)(O)C#Cc1ccc(NC(=O)c2cc(N)cc(C(=O)Nc3ccc(C#CC(C)(C)O)cc3)c2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.63
▸ L3MBTL1 Q9Y468 1/20 0.63
▸ MAPT P10636 2/20 0.60
▸ SNCA P37840 1/20 0.44
▸ MEN1 O00255 3/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ POLB P06746 1/20 0.44
▸ PKM P14618 1/20 0.44
▸ APEX1 P27695 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ F7 P08709 1/20 0.43
▸ F3 P13726 1/20 0.43
▸ PTGS1 P23219 4/20 0.42
▸ HTT P42858 1/20 0.42
▸ HDAC3 O15379 2/20 0.41
▸ HDAC6 Q9UBN7 2/20 0.41
▸ RAB9A P51151 3/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13023070 0.86 LMNA (0.47) LMNAL3MBTL1MAPTMEN1KMT2A
SCHEMBL13022960 0.83 LMNA (0.47) LMNAL3MBTL1MAPTPTGS1TOP1
SCHEMBL13023096 0.82 RAB9A (0.56) LMNAMAPTSNCAMEN1KMT2A
SCHEMBL13023087 0.80 MEN1 (0.50) LMNAMAPTSNCAMEN1KMT2A
SCHEMBL13023104 0.79 MEN1 (0.58) LMNASNCAMEN1KMT2APOLB
SCHEMBL13023110 0.79 TP53 (0.58) LMNAMAPTSNCAMEN1KMT2A
SCHEMBL13299906 0.79 MLYCD (0.52) LMNAMAPTSNCAMEN1KMT2A
SCHEMBL13066089 0.79 MEN1 (0.54) LMNAMAPTSNCAMEN1KMT2A
SCHEMBL13023046 0.77 MEN1 (0.51) LMNAMAPTSNCAMEN1KMT2A
SCHEMBL10952359 0.76 MEN1 (0.74) LMNAMAPTSNCAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286353-A1 ACETYLENE COMPOUND, SALT THEREOF, CONDENSATE THEREOF, AND COMPOSITION THEREOF FUJIFILM CORPORATION (JP) 2010-11-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286353-A1 ACETYLENE COMPOUND, SALT THEREOF, CONDENSATE THEREOF, AND COMPOSITION THEREOF KAT8, HDAC10, SSRP1 LMNA 413/4885L3MBTL1 1275/4885MAPT 2046/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback